G

Guerbet
GBT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€200.61M
EV
€547.59M
Shares Outstanding
12.60M
Beta
0.81
Industry
Medical - Devices

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
Number of Analysts
4
P/E 2025E
48.30x
P/Revenue 2025E
0.25x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Guerbet SA

gainify

G

Guerbet SA

GBT

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ...

Sector

Healthcare

Industry

Medical - Devices

CEO

Hale, David

Employees

2,842

IPO Date

2000-01-03

Headquarters

15, rue des Vanesses, Zone Paris Nord II, Villepinte, Ile-de-France, 93420, France

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.